Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2022 Publisher: ViiV Healthcare UK Limited, 980 Great West Road, Brentford, Middlesex, TW8 9GS
Retrovir 10 mg/ml IV Concentrate for Solution for Infusion.
| Pharmaceutical Form |
|---|
|
Concentrate for solution for infusion (Sterile concentrate). Retrovir IV for Infusion is a clear, nearly colourless, sterile aqueous solution with a pH of approximately 5.5. |
Vials containing zidovudine 200 mg in 20ml solution (10 mg zidovudine/ml).
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Zidovudine |
Zidovudine is an antiviral agent which is highly active in vitro against retroviruses including the Human Immunodeficiency Virus (HIV). |
| List of Excipients |
|---|
|
Hydrochloric acid (pH for adjustment) |
Type I glass vial (amber, neutral glass) with chlorobutyl rubber stopper containing 20ml sterile concentrate, available in pack sizes of 5.
ViiV Healthcare UK Limited, 980 Great West Road, Brentford, Middlesex, TW8 9GS
PL 35728/0005
Date of first authorisation: 20 April 1993
Date of last renewal: 19 July 2011
| Drug | Countries | |
|---|---|---|
| RETROVIR | Austria, Australia, Canada, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
